- Report
- January 2026
- 168 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- August 2025
- 150 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- June 2026
- 160 Pages
Global
From €3146EUR$3,499USD£2,697GBP
- Report
- April 2026
- 160 Pages
Global
From €2985EUR$3,320USD£2,559GBP
€3731EUR$4,150USD£3,199GBP
- Report
- October 2025
- 160 Pages
Global
From €2841EUR$3,160USD£2,436GBP
€3551EUR$3,950USD£3,045GBP
- Report
- October 2025
- 160 Pages
Global
From €2841EUR$3,160USD£2,436GBP
€3551EUR$3,950USD£3,045GBP
- Report
- September 2025
- 150 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- March 2026
- 160 Pages
Global
From €3500EUR$4,170USD£3,105GBP
- Report
- March 2026
- 194 Pages
Global
From €3500EUR$4,170USD£3,105GBP
- Report
- October 2025
- 112 Pages
Global
From €3500EUR$4,170USD£3,105GBP
- Report
- September 2025
- 99 Pages
Global
From €3500EUR$4,170USD£3,105GBP
- Report
- January 2026
- 164 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- September 2025
- 150 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- March 2026
- 150 Pages
Global
From €3372EUR$3,750USD£2,890GBP
- Report
- January 2026
- 138 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- October 2025
- 87 Pages
Global
From €4046EUR$4,500USD£3,468GBP
- Report
- August 2025
- 140 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- August 2025
- 101 Pages
Global
From €2652EUR$2,950USD£2,274GBP
- Report
- February 2026
- 100 Pages
Middle East, Africa
From €4315EUR$4,799USD£3,699GBP
- Report
- April 2026
- 180 Pages
Middle East, Africa
From €5350EUR$5,950USD£4,586GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more